Stretch Marks on Abdomen

Striae; Albicantes Clinical Trial

Official title: A Split-body, Double-blinded, Placebo-controlled Trial of Stratacel® Wound Dressing After Laser Treatment of Striae Alba

Status Active, not recruiting

Clinical Trial Summary

The primary objective of this study is to determine the effect of Stratacel® wound dressing on cosmetic outcomes following 1064/532nm picosecond laser (Picoway®, Syneron Candela Corp, Wayland, MA, USA) treatment of abdominal striae alba. Secondary objectives include examining the effect of Stratacel® wound dressing on post-laser healing and symptomatology.

Clinical Trial Description

Twenty adult subjects with abdominal striae alba will be enrolled. All striae will be treated using the 1064/532nm picosecond laser with designated and standardized settings (Appendix A). The abdominal striae treatment region will then be split across the body vertically with one half randomized to Stratacel® and the other to placebo, clear ultrasound gel (Aquasonic). A blinded study coordinator will apply the products to each randomized half-abdomen immediately following laser treatment.

A total of 3 treatments will be completed at 1 month intervals. Blinded-investigator and subject self-assessments will be performed at post-treatment days 2, 5, 7, and 10 after each laser session. Assessments will also be performed 1 and 3 months after the final laser treatment. ;

Related Conditions & MeSH terms

• Striae; Albicantes

• NCT number: NCT03750422
• Study type: Interventional
• Source: Goldman, Butterwick, Fitzpatrick and Groff
• Status: Active, not recruiting
• Phase: N/A
• Start date: July 1, 2018
• Completion date: December 31, 2019